Camber Capital Management as of June 30, 2013
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 41 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 12.3 | $120M | 750k | 160.01 | |
| WellPoint | 12.2 | $119M | 1.5M | 81.84 | |
| Mylan | 5.7 | $56M | 1.8M | 31.03 | |
| Quest Diagnostics Incorporated (DGX) | 5.0 | $49M | 800k | 60.63 | |
| Vanguard Health Systems | 4.3 | $42M | 2.0M | 20.74 | |
| Volcano Corporation | 4.1 | $40M | 2.2M | 18.13 | |
| Hologic (HOLX) | 4.0 | $39M | 2.0M | 19.30 | |
| Teva Pharmaceutical Industries (TEVA) | 3.8 | $37M | 950k | 39.20 | |
| Masimo Corporation (MASI) | 3.8 | $37M | 1.8M | 21.20 | |
| Cardinal Health (CAH) | 3.6 | $35M | 750k | 47.20 | |
| Humana (HUM) | 3.5 | $34M | 400k | 84.38 | |
| CONMED Corporation (CNMD) | 3.2 | $31M | 1.0M | 31.24 | |
| Alnylam Pharmaceuticals (ALNY) | 3.2 | $31M | 1.0M | 31.01 | |
| Actavis | 2.6 | $25M | 200k | 126.22 | |
| Wright Medical | 2.3 | $22M | 850k | 26.21 | |
| MAKO Surgical | 2.2 | $22M | 1.8M | 12.05 | |
| Given Imaging | 2.2 | $21M | 1.5M | 14.01 | |
| Universal Health Services (UHS) | 1.7 | $17M | 250k | 66.96 | |
| AngioDynamics (ANGO) | 1.5 | $15M | 1.3M | 11.28 | |
| UnitedHealth (UNH) | 1.4 | $13M | 200k | 65.48 | |
| InterMune | 1.3 | $13M | 1.4M | 9.62 | |
| Derma Sciences | 1.3 | $13M | 950k | 13.35 | |
| Alere | 1.3 | $12M | 500k | 24.50 | |
| Momenta Pharmaceuticals | 1.2 | $12M | 800k | 15.06 | |
| Cardionet | 1.1 | $11M | 1.8M | 5.90 | |
| Idenix Pharmaceuticals | 1.0 | $9.9M | 2.8M | 3.61 | |
| Magellan Health Services | 1.0 | $9.8M | 175k | 56.08 | |
| GenMark Diagnostics | 1.0 | $9.8M | 950k | 10.34 | |
| Amedisys (AMED) | 1.0 | $9.3M | 800k | 11.62 | |
| Boston Scientific Corporation (BSX) | 0.9 | $9.3M | 1.0M | 9.27 | |
| WellCare Health Plans | 0.9 | $9.2M | 166k | 55.55 | |
| Cross Country Healthcare (CCRN) | 0.8 | $7.9M | 1.5M | 5.16 | |
| Protalix BioTherapeutics | 0.8 | $7.4M | 1.5M | 4.91 | |
| Rockwell Medical Technologies | 0.7 | $7.2M | 2.0M | 3.61 | |
| Novavax | 0.7 | $6.6M | 3.2M | 2.05 | |
| Arrowhead Research | 0.6 | $6.2M | 3.1M | 2.00 | |
| Celgene Corp right 12/31/2011 | 0.5 | $4.9M | 658k | 7.41 | |
| Universal American | 0.5 | $4.6M | 520k | 8.89 | |
| Bluebird Bio (BLUE) | 0.4 | $3.7M | 150k | 24.97 | |
| Natus Medical | 0.2 | $1.9M | 141k | 13.65 | |
| Anthera Pharmaceuticals | 0.0 | $0 | 400k | 0.00 |
